Associations between personality traits and adherence to treatment in patients with primary open–angle glaucoma in an African population

References

• Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence 2008; 2: 303–314.
   PubMedGoogle Scholar
• Resnikoff S, Pascolini D, Etya’-Ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844–851.
   PubMed Web of Science ®Google Scholar
• Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S, et al. Prevalence of glaucoma in an African population. Eye 2004; 18: 491–497.
   PubMed Web of Science ®Google Scholar
• Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies: Part I. Prevalence findings. Ophthalmology 1989; 96: 1363–1368.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Niranjan GD, Agrawal SS, et al. Recent advances in pharmacotherapy of glaucoma. Indian J Pharmacol 2008; 40: 197–208.
   PubMed Web of Science ®Google Scholar
• Mansouri K, Medeiros FA, Weinreb RN. Global rates of glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 2013; 251: 2609–2615.
   PubMed Web of Science ®Google Scholar
• Kyei S, Obeng PA, Kwarteng MA, et al. Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: any lessons for public health intervention?. PLoS One 2021;16:e0245486.
   PubMed Web of Science ®Google Scholar
• Pappa C, Hyphantis T, Pappa S, et al. Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. J Psychosom Res 2006; 61: 609–617.
   PubMed Web of Science ®Google Scholar
• Konstas AG, Maskaleris G, Gratsonidis S, et al. Compliance and viewpoint of glaucoma patients in Greece. Eye 2000; 14: 752–756.
   PubMed Web of Science ®Google Scholar
• Ocansey S, Kyei S, Diafo A, et al. Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana–a retrospective cross-sectional study from three referral facilities. BMC Health Serv Res 2016; 16: 1–8.
   PubMed Web of Science ®Google Scholar
• Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma 2003; 12: 393–398.
   PubMed Web of Science ®Google Scholar
• Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9: 11–23.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology 2015; 122: 1308–1316.
   PubMed Web of Science ®Google Scholar
• Hibbeler HL. Personality patterns of white adults with primary glaucoma. Am J Ophthalmol 1947; 30: 181–186.
   PubMed Web of Science ®Google Scholar
• Shaheen O, Labib MA, Abboud I, et al. Some ophthalmological factors affecting the personality patterns in primary glaucoma patients as determined by the Minnesota Multiphasic Personality Inventory. Bull Ophthalmol Soc Egypt 1970; 63: 139–140.
   PubMedGoogle Scholar
• Çakmak H, Altinyazar V, Yilmaz SG, et al. The temperament and character personality profile of the glaucoma patient. BMC Ophthalmol 2015; 15: 1–8.
   PubMed Web of Science ®Google Scholar
• Mabuchi F, Yoshimura K, Kashiwagi K, et al. Personality assessment based on the five-factor model of personality structure in patients with primary open-angle glaucoma. Jpn J Ophthalmol 2005; 49: 31–35.
   PubMed Web of Science ®Google Scholar
• Lim MC, Shiba DR, Clark IJ, et al. Personality type of the glaucoma patient. J Glaucoma 2007; 16: 649–654.
   PubMed Web of Science ®Google Scholar
• Chen J, Lin ZN, Tao YT, et al. Influences of personality characteristics and coping modes on anxiety in primary glaucoma patients. Int J Ophthalmol 2019; 12: 1163–1169.
   PubMed Web of Science ®Google Scholar
• Bartram D. Scalar equivalence of OPQ32: Big Five profiles of 31 countries. J Cross Cult Psychol 2013; 44: 61–83.
   Web of Science ®Google Scholar
• Rentfrow PJ, Jokela M, Lamb ME. Regional personality differences in Great Britain. PLoS One 2015; 10: e0122245.
   PubMed Web of Science ®Google Scholar
• Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma 2012; 21: 234–240.
   PubMed Web of Science ®Google Scholar
• Keltner JL, Johnson CA, Cello KE, et al.; Ocular Hypertension Treatment Study Group. Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol 2003; 121: 643–650.
   PubMedGoogle Scholar
• Intiful FD, Oddam EG, Kretchy I, et al. Exploring the relationship between the big five personality characteristics and dietary habits among students in a Ghanaian University. BMC Psychol 2019; 7: 1–7.
   PubMed Web of Science ®Google Scholar
• De Raad B, Mlačić B. Big Five Factor Model, theory and structure. Int Encycl Soc Behav Sci 2015; 2: 559–566.
   Google Scholar
• Adeniran A, Akinyinka M, Wright KO, et al. Personality traits, medication beliefs & adherence to medication among diabetic patients attending the diabetic clinic in a teaching hospital in southwest Nigeria. J Diabetes Mellitus 2015; 5: 319–329.
   Google Scholar
• Anbesse DH, Yibekal BT, Assefa NL. Adherence to topical glaucoma medications and associated factors in Gondar University Hospital Tertiary Eye Care Center, northwest Ethiopia. Eur J Ophthalmol 2019; 29: 189–195.
   PubMed Web of Science ®Google Scholar
• Onwubiko SN, Nwachukwu NZ, Eze B. Glaucoma medications: issues with adherence in a tertiary hospital in Nigeria. Fam Med Prim Care Rev 2020; 22: 302–306.
   Web of Science ®Google Scholar
• Holló G, Kóthy P, Géczy A, et al. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma. J Glaucoma 2009; 18: 288–292.
   PubMed Web of Science ®Google Scholar
• Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009; 15: 728–740.
   PubMed Web of Science ®Google Scholar
• Nakano T, Kodaka F, Tsuneoka H. Differences in neuroticism between patients with glaucoma who have discontinued visits to ophthalmologists and those who make regular visits: implications for adherence to topical glaucoma medications. Ophthalmol Ther 2016; 5: 207–214.
   PubMedGoogle Scholar
• Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma 2008; 17: 552–557.
   PubMed Web of Science ®Google Scholar
• Bubella RM, Bubella DM, Cillino S. Type a behavior pattern: is it a risk factor for open-angle chronic glaucoma? J Glaucoma 2014; 23: 199–201.
   PubMed Web of Science ®Google Scholar
• Méndez-Ulrich JL, Sanz A, Feliu-Soler A, et al. Could white coat ocular hypertension affect to the accuracy of the diagnosis of Glaucoma? Relationships between anxiety and intraocular pressure in a simulated clinical setting. Appl Psychophysiol Biofeedback 2018; 43: 49–56.
   PubMed Web of Science ®Google Scholar
• Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol 2012; 96: 821–825.
   PubMed Web of Science ®Google Scholar
• Odberg T, Jakobsen J, Hultgren S. The impact of glaucoma on the quality of life of patients in Norway. Acta Ophthalmol Scand 2001; 79: 116–120.
   PubMedGoogle Scholar
• Méndez-Ulrich JL, Casas N, Sanz A. Ocular white coat hypertension: a pilot study. Ansiedad Y Estrés 2013; 19: 41–51.
   Google Scholar
• Chiquet C, Denis P The neuroanatomical and physiological bases of variations in intraocular pressure. J Fr Ophtalmol 2004; 27: 2S11–2S18.
   PubMed Web of Science ®Google Scholar
• Warrian KJ, Spaeth GL, Lankaranian D, et al. The effect of personality on measures of quality of life related to vision in glaucoma patients. Br J Ophthalmol 2009; 93: 310–315.
   PubMed Web of Science ®Google Scholar
• Breivik G, Sand TS, Sookermany AM. Risk-taking attitudes and behaviors in the Norwegian population: the influence of personality and background factors. J Risk Res 2020; 23: 1504–1523.
   Web of Science ®Google Scholar
• McGhee RL, Ehrler DJ, Buckhalt JA, et al. The relation between five-factor personality traits and risk-taking behavior in preadolescents. Psychology 2012; 3: 558–561.
   Google Scholar
• Leske MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol 2004; 15: 102–106.
   PubMedGoogle Scholar
• Kharod BV, Johnson PB, Nesti HA, et al. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients. J Glaucoma 2006; 15: 244–247.
   PubMed Web of Science ®Google Scholar
• Jampel HD, Parekh P, Johnson E, et al. Chart documentation by general physicians of the glaucoma medications taken by their patients. Am J Ophthalmol 2005; 140: 344–345.
   PubMed Web of Science ®Google Scholar
• Miller W, Rollnick S. Motivational interviewing: Helping people change. 3rd ed. New York: Guilford Press; 2013.
   Google Scholar
• Philippin H, Matayan E, Knoll KM, et al. Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial. Lancet Glob Health 2021; 9: e1589–99.
   PubMed Web of Science ®Google Scholar
• Realini T, Shillingford-Ricketts H, Burt D, et al. West Indies glaucoma laser study (WIGLS): 12-month efficacy of selective laser trabeculoplasty in Afro-Caribbeans with glaucoma. Am J Ophthalmol 2017; 184: 28–33.
   PubMed Web of Science ®Google Scholar